BioXcel Therapeutics, Inc. (BTAIQ) vs cbdMD, Inc. (YCBD)
- BioXcel Therapeutics, Inc. BTAIQ 0.03 0.00%
- cbdMD, Inc. YCBD 0.35 −2.78%
BioXcel Therapeutics, Inc. and cbdMD, Inc. are both Drug Manufacturers Specialty & Generic companies. cbdMD, Inc. is the larger, with a market value of $4.0M against $2.3M — 1.7× the size. BioXcel Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; cbdMD, Inc. trades at 41.2×. cbdMD, Inc. grew revenue faster over the last twelve months: 10.0% against −14.5%. cbdMD, Inc. has the higher net margin (−14.7% vs −9,549.9%) and the lower return on invested capital (−29.8% vs 0.00%). Across the 16 metrics below, cbdMD, Inc. leads on 12 and BioXcel Therapeutics, Inc. on 4.
Valuation
Profitability
| Metric | BTAIQ | YCBD | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 53.10% | 57.68% | 53.94% |
| Operating margin | (6,054.72%) | (13.87%) | 0.00% |
| Net margin | (9,549.87%) | (14.71%) | 0.00% |
| Free cash flow margin | (6,860.38%) | (11.51%) | 0.00% |
| Return on equity | 63.52% | (43.01%) | (0.40%) |
| Return on assets | (259.62%) | (26.73%) | (3.32%) |
| Return on invested capital | 0.00% | (29.78%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack